GLP-1 receptor agonist discontinuation and cardiovascular events and all-cause mortality in people with type 2 diabetes: a retrospective cohort study

The Lancet Regional Health - Europe · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles